Am J Transplant, Volume 16, Suppl 3 Archives - Page 53 of 180 - ATC Abstracts

2016 American Transplant Congress
In Vivo and In Vitro Characterization of 1.5 mm Ba²⁺-Alginate Macro-Encapsulated Cynomolgus Monkey Islets.
M. Bochenek,¹ J. McGarrigle,¹ J. Mendoza-Elias,¹ E. Marchese,¹ M. Nourmohammadzadeh,¹ Y. Wang,¹ A. Khan,¹ M. Omami,¹ C.-C. Yeh,¹ I. Lacik,² B. Strand,³ J. Oberholzer.¹
¹Transplant Surgery, University of Iliinois at Chicago, Chicago, IL; ²Biomaterials Research, Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovakia (Slovak Republic); ³Biotechnology, Norwegian University of Science and Technology, Trondheim, Norway.
Introduction:Micro-encapsulation of islets for the treatment of Type I diabetes has shown limited efficacy in small-scale clinical trials. The lack of success may be related…
2016 American Transplant Congress
Diagnosis of Pulmonary Nocardiosis: A Single Center Study.
D. Wray,¹ S. Win,² M. Heincelman,¹ L. Steed,¹ J. Cantey.¹
¹Medical University of South Carolina, Charleston, SC; ²Los Palos Medical Associates, Salinas, CA.
Pulmonary nocardiosis (PN) is an uncommon infection seen typically in immunocompromised (IC) patients. Definitive diagnosis depends on culture of nocardia along with a clinical presentation…
2016 American Transplant Congress
The Preventive and Therapeutic Effect of Immunoglobulin on Infectious Complications in Donation After Cardiac Death Liver Transplant Recipients: A Prospective Randomized Controlled Study.
A. Yang, Z. Guo, W. Ju, Y. Chen, M. Han, X. Wang, D. Wang, Y. Ma, A. Hu, X. Zhu, X. He.
Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Aims: To prospectively investigate the preventive and therapeutic effect of immunoglobulin on infectious complications in DCD liver transplant recipients, and synthetically evaluate its influence on…
2016 American Transplant Congress
Post-Trial Experience with Belatacept: A Large Single Center Experience.
A. Adams, C. Garrett, J. Goldstein, R. Zhang, A. Guasch, S. Pastan, R. Patzer, A. Kirk, T. Pearson, C. Larsen.
Emory Transplant Center, Atlanta, GA.
Evaluation of belatacept in clinical trials revealed significant improvements in renal function and cardiovascular risk leading to superior survival. Despite these proven benefits higher rates…
2016 American Transplant Congress
Vaccination Status and Titers Before and After Pediatric Renal Transplantation: An Analysis of the CERTAIN Registry.
B. Höcker,¹ M. Aguilar,¹ P. Schnitzler,² L. Pape,² L. Dello Strologo,² N. Webb,² M. Bald,² G. Genc,² H. Billing,² J. König,² A. Büscher,² F. Thiel,² S. Marks,² M. Pohl,² M. Wigger,² R. Topaloglu,² A. Fichtner,¹ S. Rieger,¹ K. Krupka,¹ B. Tönshoff.¹
¹University Children's Hospital, Heidelberg, Germany; ²CERTAIN Research Community, Italy, United Kingdom, Turkey, Germany.
Purpose:Prevention of systemic viral and bacterial infections by effective vaccination in kidney allograft recipients is of vital importance, but data on the vaccination status in…
2016 American Transplant Congress
Incidence of Post-Transplant Cardiovascular Disease After Pediatric Kidney Transplantation.
O. Serrano,¹ A. Bangdiwala,² D. Vock,² W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas,¹ B. Chavers.³
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics, Univ. of Minnesota, Minneapolis, MN; ³Pediatrics, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: Kidney transplant (KTx) recipients have increased risk of cardiovascular disease (CVD), related to time on dialysis and post-KTx immunosuppression. To date, the incidence of…
2016 American Transplant Congress
Efficacy of Nine National Policies Reimbursing and Incentivizing Live Organ Donation.
V. Apte, S. Fry-Revere.
American Living Organ Donor Network, Lovettsville, VA.
Background: Organ shortage is a massive global issue, and the high costs of living organ donation only exacerbate the problem. In order to encourage citizens…
2016 American Transplant Congress
Pediatric Liver Transplant Exception Request Narratives – How Do We Justify Requests?
H. Braun,³ S. Rhee,¹ J. Dodge,² J. Roberts,² E. Perito.¹
¹Pediatrics, University of California-San Francisco, San Francisco, CA; ²Surgery, University of California-San Francisco, San Francisco, CA; ³School of Medicine, University of California-San Francisco, San Francisco, CA.
Purpose: Over 50% of pediatric liver transplant (LT) candidates receive exceptions to increase PELD/MELD; more than [frac12] are non-standard exception requests (NSER) based on narrative…
2016 American Transplant Congress
Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Lateral Section Grafts.
K. Lee, K. Kim, S. Kim, J. Lee, J. Lee, N. Lee, C. Cho, S. Lee, G. Choi, C. Kwon, J.-W. Joh, S.-K. Lee.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
In pediatric end-stage liver disease patients, the use of partial liver grafts from adult living donors has been increasing for liver transplantation due to a…
2016 American Transplant Congress
Urinary CXCL9 Protein as Biomarker for BK Polyoma Viremia.
N. Sarabu,¹ R. El-Rifai,² J. Augustine,¹ A. Padiyar,¹ A. Huml,¹ T. Young,¹ V. Rodriguez,¹ D. Hricik.¹
¹Division of Nephrology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; ²Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
Introduction: BK infection is common in kidney transplant patients and can result in accelerated loss of allografts. Management involves empiric lowering of immunosuppression, which can…